Folium Science
PrivateLast Round
Grant
Feb 12, 2024
Total Funding Raised
$756,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Folium Science operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Grant round in February 2024.
Folium Science is a UK-based biotechnology company founded in 2016 that develops a CRISPR-Cas based technology, Guided Biotics®, to selectively remove harmful bacteria in livestock to reduce antibiotic use and improve agricultural productivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Folium Science Comparables
Compare Folium Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NovoBind Livestock Therapeutics Inc. | 81% | |
| PhageLab | 81% | |
| Proteon Pharmaceuticals | 80% |
For institutional investors. Book with your work email.
Folium Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 12, 2024 | ||||
| Grant | Feb 1, 2024 | ||||
| Strategic | May 18, 2022 | ||||
| Grant | Aug 26, 2020 | ||||
| Grant | Jul 6, 2019 | ||||
Accelerator | May 1, 2019 |
For institutional investors. Book with your work email.
Folium Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeckfonden BioCapital | Seed |
| Innovate UK | Grant |
| Department for Environment, Food & Rural Affairs | Grant |
| North-East Family Office | Seed |
| The Pearse Lyons Cultivator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 52% MoM.
- Apr 17, 2026
Monthly visitors grew 186% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- sells_assets_toAug 25, 2026
Folium Science sells its technology platform and pipeline assets to BiomEdit, Inc., including an approved poultry feed additive and CRISPR-based microbiome technology, in a completed transaction with undisclosed terms on Aug 25th '26.
For institutional investors. Book with your work email.
Folium Science Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Folium Science's valuation, stock price, and market status.
Is Folium Science a public or private company?
Folium Science is a private company.
What is the current stock price of Folium Science?
Folium Science is a private company, so its shares have no public market price. Caplight tracks Folium Science's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Folium Science worth (valuation)?
Valuation information for Folium Science is not publicly available.
Can I buy Folium Science stock?
Folium Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Folium Science's last funding round?
Folium Science's most recent funding round was Grant on February 12, 2024.
Who are the main investors in Folium Science?
Key investors in Folium Science include Lundbeckfonden BioCapital.
Will Folium Science IPO soon?
No public IPO plans have been announced for Folium Science.
How can I track Folium Science secondary market activity?
Caplight tracks bids, offers, and trades in Folium Science's shares on secondary markets.